14.56 +0.04 (0.27%)
RDEA
Stock Details
Last Trade:14.56 Change:+0.04 (0.27%) Prev Close:14.52 Open: 14.63 Days Range:14.50 – 14.93 52 Week Range: 8.78 - 21.35 Volume:209292 P/E: N/AEPS:-2.17
View AllRecent Alerts 02/10/10
Recent Alert on 01/28/10 at 7:31am
Soleil Securities Initiates Coverage on Ardea Biosciences (RDEA) with a Buy
Soleil Securities Initiates Coverage on Ardea Biosciences (RDEA) with a Buy
Soleil Securities initiates coverage on Ardea Biosciences (Nasdaq: RDEA) with a Buy. Price target $27. Soleil analyst says, "We are initiating coverage of Ardea Biosciences with a Buy rating and 12 month price target of $27, based on our... Read More
Recent Alert on 12/18/09 at 9:32am
Jefferies & Co Initiates/Resumes Coverage on Pharma/Biotechnology Stocks
Jefferies & Co Initiates/Resumes Coverage on Pharma/Biotechnology Stocks
Recent Alert on 12/03/09 at 8:43am
Brean Murray Initiates Coverage on Ardea Biosciences (RDEA) with a Buy; Addressing a Clear Need
Brean Murray Initiates Coverage on Ardea Biosciences (RDEA) with a Buy; Addressing a Clear Need
Recent Alert on 12/01/09 at 8:15am
Ardea Biosciences (RDEA) Announces Positive Results from RDEA594 Pharmacodynamic Study
Ardea Biosciences (RDEA) Announces Positive Results from RDEA594 Pharmacodynamic Study
View AllRecent Press Releases
Press Release on 02/09/10 at 8:30am
Ardea Biosciences Announces Appointment of Felix J. Baker, Ph.D. to Board of Directors
Ardea Biosciences Announces Appointment of Felix J. Baker, Ph.D. to Board of Directors
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 01/28/10 at 12:10pm
Analyst Upgrades, Downgrades and Initiations: APA, BKC, CAT, NFLX, KFT, QCOM, ROK ...
Analyst Upgrades, Downgrades and Initiations: APA, BKC, CAT, NFLX, KFT, QCOM, ROK ...
Blog Posts on 10/30/09 at 10:55am
Analyst upgrades, downgrades and initiations: JCG, K, MON, TOL, TXN ...
Analyst upgrades, downgrades and initiations: JCG, K, MON, TOL, TXN ...
Blog Posts on 07/21/09 at 3:10pm
FDA Calendar Updates: STAAR Surgical, Spectrum Pharma, Allergan, Incyte, Ardea
FDA Calendar Updates: STAAR Surgical, Spectrum Pharma, Allergan, Incyte, Ardea

